| Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial SSAY Biere, MI van Berge Henegouwen, KW Maas, L Bonavina, ... The Lancet 379 (9829), 1887-1892, 2012 | 1822 | 2012 |
| Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study D Nepogodiev, A Bhangu, JC Glasbey, E Li, OM Omar, JFF Simoes, ... The Lancet 396 (10243), 27-38, 2020 | 1808 | 2020 |
| Benchmarking complications associated with esophagectomy DE Low, MK Kuppusamy, D Alderson, I Cecconello, AC Chang, G Darling, ... Annals of surgery 269 (2), 291-298, 2019 | 668 | 2019 |
| Timing of surgery following SARS‐CoV‐2 infection: an international prospective cohort study H Gacaferi, GS Collaborative, COVIDSurg Collaborative Anaesthesia 76 (6), 2021 | 532* | 2021 |
| Minimally invasive versus open esophageal resection: three-year follow-up of the previously reported randomized controlled trial: the TIME trial J Straatman, N Van Der Wielen, MA Cuesta, F Daams, JR Garcia, ... Annals of surgery 266 (2), 232-236, 2017 | 516 | 2017 |
| Learning curve and associated morbidity of minimally invasive esophagectomy: a retrospective multicenter study F van Workum, MHBC Stenstra, GHK Berkelmans, AE Slaman, ... Annals of surgery 269 (1), 88-94, 2019 | 268 | 2019 |
| Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer (preSANO): a prospective multicentre, diagnostic cohort study BJ Noordman, MCW Spaander, R Valkema, BPL Wijnhoven, ... The Lancet Oncology 19 (7), 965-974, 2018 | 239 | 2018 |
| Defining benchmarks for transthoracic esophagectomy: a multicenter analysis of total minimally invasive esophagectomy in low risk patients HM Schmidt, SS Gisbertz, J Moons, I Rouvelas, J Kauppi, A Brown, E Asti, ... Annals of surgery 266 (5), 814-821, 2017 | 239 | 2017 |
| Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study J Glasbey, A Ademuyiwa, A Adisa, E AlAmeer, AP Arnaud, F Ayasra, ... The Lancet Oncology 22 (11), 1507-1517, 2021 | 233 | 2021 |
| Quality of life and late complications after minimally invasive compared to open esophagectomy: results of a randomized trial KW Maas, MA Cuesta, MI van Berge Henegouwen, J Roig, L Bonavina, ... World journal of surgery 39 (8), 1986-1993, 2015 | 216 | 2015 |
| A propensity score matched analysis of open versus minimally invasive transthoracic esophagectomy in the Netherlands MFJ Seesing, SS Gisbertz, L Goense, R Van Hillegersberg, HM Kroon, ... Annals of surgery 266 (5), 839-846, 2017 | 214 | 2017 |
| Stromal-derived interleukin 6 drives epithelial-to-mesenchymal transition and therapy resistance in esophageal adenocarcinoma EA Ebbing, AP van der Zalm, A Steins, A Creemers, S Hermsen, ... Proceedings of the National Academy of Sciences 116 (6), 2237-2242, 2019 | 163 | 2019 |
| Neoadjuvant chemoradiotherapy combined with atezolizumab for resectable esophageal adenocarcinoma: a single-arm phase II feasibility trial (PERFECT) T Van Den Ende, NC De Clercq, MI van Berge Henegouwen, SS Gisbertz, ... Clinical Cancer Research 27 (12), 3351-3359, 2021 | 160 | 2021 |
| Hartmann's procedure versus sigmoidectomy with primary anastomosis for perforated diverticulitis with purulent or faecal peritonitis (LADIES): a multicentre, parallel-group … DPV Lambrichts, S Vennix, GD Musters, IM Mulder, HA Swank, ... The Lancet Gastroenterology & Hepatology 4 (8), 599-610, 2019 | 157 | 2019 |
| Laparoscopic versus open gastrectomy for gastric cancer (LOGICA): a multicenter randomized clinical trial A van der Veen, HJF Brenkman, MFJ Seesing, L Haverkamp, MDP Luyer, ... Journal of Clinical Oncology, 978-989, 2021 | 142 | 2021 |
| Intrathoracic versus cervical anastomosis and predictors of anastomotic leakage after oesophagectomy for cancer JAH Gooszen, L Goense, SS Gisbertz, JP Ruurda, R Van Hillegersberg, ... Journal of British Surgery 105 (5), 552-560, 2018 | 139 | 2018 |
| Laparoscopic versus open gastrectomy for gastric cancer, a multicenter prospectively randomized controlled trial (LOGICA-trial) L Haverkamp, HJF Brenkman, MFJ Seesing, SS Gisbertz, ... BMC cancer 15, 1-7, 2015 | 133 | 2015 |
| Anastomotic leakage after esophagectomy for esophageal cancer: definitions, diagnostics, and treatment M Fabbi, ERC Hagens, MI van Berge Henegouwen, SS Gisbertz Diseases of the Esophagus 34 (1), doaa039, 2021 | 114 | 2021 |
| Open versus minimally invasive total gastrectomy after neoadjuvant chemotherapy: results of a European randomized trial N van der Wielen, J Straatman, F Daams, R Rosati, P Parise, J Weitz, ... Gastric Cancer 24, 258-271, 2021 | 109 | 2021 |
| Minimally invasive intrathoracic anastomosis after Ivor Lewis esophagectomy for cancer: a review of transoral or transthoracic use of staplers KW Maas, S Biere, JJG Scheepers, SS Gisbertz, V Turrado Rodriguez, ... Surgical endoscopy 26, 1795-1802, 2012 | 104 | 2012 |
Hanneke van LaarhovenVerified email at amc.uva.nl
